tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Vir Biotechnology initiated with an Outperform at Raymond James
PremiumThe FlyVir Biotechnology initiated with an Outperform at Raymond James
19d ago
Vir Biotechnology initiated with an Outperform at Raymond James
Premium
The Fly
Vir Biotechnology initiated with an Outperform at Raymond James
20d ago
Positive Outlook on Vir Biotechnology’s VIR-5500 Amid Competitive mCRPC Market
Premium
Ratings
Positive Outlook on Vir Biotechnology’s VIR-5500 Amid Competitive mCRPC Market
2M ago
Vir Biotechnology’s Earnings Call: Mixed Sentiment Amid Progress
PremiumCompany AnnouncementsVir Biotechnology’s Earnings Call: Mixed Sentiment Amid Progress
3M ago
Vir Biotechnology: Strong Financials and Promising Pipeline Justify Buy Rating
Premium
Ratings
Vir Biotechnology: Strong Financials and Promising Pipeline Justify Buy Rating
3M ago
Vir Biotechnology: Strong Financial Health and Promising Clinical Progress Justify Buy Rating
Premium
Ratings
Vir Biotechnology: Strong Financial Health and Promising Clinical Progress Justify Buy Rating
3M ago
Vir Biotechnology Poised for Growth: Buy Rating Reiterated Amid Clinical and Financial Advancements
PremiumRatingsVir Biotechnology Poised for Growth: Buy Rating Reiterated Amid Clinical and Financial Advancements
5M ago
Vir Biotechnology price target raised to $31 from $26 at Barclays
Premium
The Fly
Vir Biotechnology price target raised to $31 from $26 at Barclays
5M ago
Vir Biotechnology’s Transformative Year: Earnings Call Insights
Premium
Company Announcements
Vir Biotechnology’s Transformative Year: Earnings Call Insights
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100